What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Immune system
His main research concerns Immunology, Uveitis, Surgery, Internal medicine and Pathology.
The various areas that Andrew D. Dick examines in his Uveitis study include Prednisolone and Immune tolerance.
His Surgery research is multidisciplinary, relying on both Intermediate uveitis and Pediatrics.
The study incorporates disciplines such as Gastroenterology and Placebo in addition to Internal medicine.
His Pathology research is multidisciplinary, incorporating perspectives in Retina, Delphi method and Microglia.
His studies deal with areas such as Adalimumab and Clinical trial as well as Randomized controlled trial.
His most cited work include:
- The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease (260 citations)
- Adalimumab in Patients with Active Noninfectious Uveitis (228 citations)
- Adalimumab in Patients with Active Noninfectious Uveitis (228 citations)
What are the main themes of his work throughout his whole career to date?
Andrew D. Dick mainly focuses on Uveitis, Immunology, Internal medicine, Pathology and Ophthalmology.
His Uveitis study integrates concerns from other disciplines, such as Adalimumab and Surgery, Retrospective cohort study, Visual acuity.
His research in Immunology focuses on subjects like Disease, which are connected to Intensive care medicine.
His Internal medicine study combines topics in areas such as Gastroenterology and Placebo.
His Pathology research integrates issues from Retina and Retinal.
His Retina research includes themes of Microglia and Cell biology.
He most often published in these fields:
- Uveitis (43.01%)
- Immunology (34.85%)
- Internal medicine (21.96%)
What were the highlights of his more recent work (between 2018-2021)?
- Retinal (15.06%)
- Cell biology (15.61%)
- Uveitis (43.01%)
In recent papers he was focusing on the following fields of study:
Andrew D. Dick mainly investigates Retinal, Cell biology, Uveitis, Confidence interval and Pediatrics.
The Retinal study combines topics in areas such as Vascular endothelial growth factor, Glaucoma and Vascular permeability.
His Cell biology research is multidisciplinary, relying on both Retinal pigment epithelium, Blood–retinal barrier and Inflammation.
The various areas that Andrew D. Dick examines in his Uveitis study include Adalimumab, Visual acuity and Arthritis.
His research investigates the connection with Adalimumab and areas like Randomized controlled trial which intersect with concerns in Placebo.
His Pediatrics research is multidisciplinary, incorporating elements of Prospective cohort study, Intermediate uveitis and Disease.
Between 2018 and 2021, his most popular works were:
- A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration (72 citations)
- A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration (72 citations)
- Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study (17 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
His primary areas of study are Ophthalmology, Glaucoma, Intraocular pressure, Uveitis and Retinal.
As part of the same scientific family, he usually focuses on Ophthalmology, concentrating on Confidence interval and intersecting with Comorbidity, Biobank and Prospective cohort study.
His Comorbidity study is concerned with Internal medicine in general.
In his research on the topic of Glaucoma, Viral vector, Pattern recognition receptor, Immunology and Vector is strongly related with Genetic enhancement.
The study incorporates disciplines such as Immunohistochemistry, Tonsil, Pathology, Inflammation and Antigen in addition to Uveitis.
He has included themes like Placebo, Visual acuity, Retrospective cohort study and Single Center in his Randomized controlled trial study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
